{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T09:50:32Z","timestamp":1774950632452,"version":"3.50.1"},"reference-count":11,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.clinthera.2025.08.014","type":"journal-article","created":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T04:01:35Z","timestamp":1757822495000},"page":"1080-1082","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Increasing the Time Interval Suppresses Adverse Effects After Concomitant Use of Nafamostat Mesylate and Levocarnitine in Dialysis Patients: Case Series"],"prefix":"10.1016","volume":"47","author":[{"given":"Lili","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaoyan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jurong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingyue","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2025.08.014_bib0001","doi-asserted-by":"crossref","first-page":"941","DOI":"10.2165\/00003088-200342110-00002","article-title":"Pharmacokinetics of l-carnitine","volume":"42","author":"Evans","year":"2003","journal-title":"Clin Pharm"},{"issue":"4 Suppl 4","key":"10.1016\/j.clinthera.2025.08.014_bib0002","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/S0272-6386(03)00113-6","article-title":"Dialysis-related carnitine disorder and levocarnitine pharmacology","volume":"41","author":"Evans","year":"2003","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1016\/j.clinthera.2025.08.014_bib0003","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.3390\/nu13041219","article-title":"Significance of levocarnitine treatment in dialysis patients","volume":"13","author":"Takashima","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.clinthera.2025.08.014_bib0004","article-title":"Carnitine supplements for people with chronic kidney disease requiring dialysis","volume":"12","author":"Nishioka","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clinthera.2025.08.014_bib0005","doi-asserted-by":"crossref","first-page":"68","DOI":"10.12998\/wjcc.v12.i1.68","article-title":"Efficacy and safety of nafamostat mesylate in patients with end-stage renal failure","volume":"12","author":"Liu","year":"2024","journal-title":"World J Clin Cases"},{"key":"10.1016\/j.clinthera.2025.08.014_bib0006","article-title":"Anaphylactic reactions caused by nafamostat mesylate during hemodialysis before surgery for carpal tunnel syndrome","volume":"2021","author":"Nakamura","year":"2021","journal-title":"Case Rep Nephrol"},{"key":"10.1016\/j.clinthera.2025.08.014_bib0007","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.krcp.2015.10.003","article-title":"Cardiac arrest caused by nafamostat mesilate","volume":"35","author":"Kim","year":"2016","journal-title":"Kidney Res Clin Pract"},{"key":"10.1016\/j.clinthera.2025.08.014_bib0008","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1093\/ndt\/7.9.980a","article-title":"Agranulocytosis in a haemodialysed patient induced by a proteinase inhibitor, nafamostate mesilate","volume":"7","author":"Okada","year":"1992","journal-title":"Nephrol Dialysis Transplant"},{"issue":"9","key":"10.1016\/j.clinthera.2025.08.014_bib0009","doi-asserted-by":"crossref","first-page":"673","DOI":"10.7326\/0003-4819-144-9-200605020-00011","article-title":"Meta-analysis: low-molecular-weight heparin and bleeding in patients with severe renal insufficiency","volume":"144","author":"Lim","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clinthera.2025.08.014_bib0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0052576","article-title":"HDAC inhibitor l-carnitine and proteasome inhibitor bortezomib synergistically exert anti-tumor activity in vitro and in vivo","volume":"7","author":"Huang","year":"2012","journal-title":"PLoS One"},{"issue":"168","key":"10.1016\/j.clinthera.2025.08.014_bib0011","article-title":"Allergy and anaphylaxis","volume":"15","author":"Smeding","year":"2024","journal-title":"Nederlands tijdschrift voor geneeskunde"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291825002966?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291825002966?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T08:56:34Z","timestamp":1774947394000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291825002966"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":11,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S0149291825002966"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2025.08.014","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increasing the Time Interval Suppresses Adverse Effects After Concomitant Use of Nafamostat Mesylate and Levocarnitine in Dialysis Patients: Case Series","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2025.08.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}